|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | Alcon Research |
|---|---|
| Information provided by: | Alcon Research |
| ClinicalTrials.gov Identifier: | NCT00051194 |
Purpose
To compare the intraocular pressure(IOP)-lowering efficacy of morning or evening instillations of a combination IOP-lowering therapy in patients with open-angle glaucoma or ocular hypertension.
| Condition | Intervention | Phase |
|---|---|---|
|
Glaucoma, Open-Angle Ocular Hypertension |
Drug: Combination IOP Lowering Therapy |
Phase II |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study |
| Official Title: | A 6-Week Safety and Efficacy Study of Combination IOP-Lowering Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension. |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Adult patients of any race and either sex with open angle glaucoma or ocular hypertension.
Contacts and Locations
More Information
| Study ID Numbers: | C-02-03 |
| Study First Received: | January 3, 2003 |
| Last Updated: | March 3, 2006 |
| ClinicalTrials.gov Identifier: | NCT00051194 History of Changes |
| Health Authority: | United States: Food and Drug Administration |
|
Glaucoma POAG OAG OHT |
|
Glaucoma Eye Diseases Glaucoma, Open-Angle Vascular Diseases |
Cardiovascular Diseases Ocular Hypertension Hypertension |